L'ANRS à la conférence HIV R4P

La conférence HIV R4P se tiendra cette année à Madrid du 21 au 25 octobre.

L’ANRS sera présente avec un symposium satellite « Social Sciences in Vaccine Trials: a Booster to Recruit Volunteers » qui se tiendra le Dimanche 21 octobre de 12h30 à 14h30 organisé conjointement avec le VRI.

Dans le prolongement de l’ouvrage de la collection sciences sociales et sida  » Recrutement-engagement dans des essais cliniques en prévention  » est paru le supplément d’octobre 2018 du JAIDS (Journal of acquired immune deficience syndrome) intitulé « Volunteers for HIV vaccine trial: A social science approach« , soutenu par l’ANRS et le VRI.

The recruitment of healthy, HIV seronegative patients to HIV preventive vaccine trials has fluctuated since the early days of their implementation. There are numerous reasons for this, including the normalisation of the epidemic, the displacement of HIV commun ity action towards other causes, the transformation of disease management and the lack of direct benefits. Vaccination is being increasingly rejected. At a time when scientific advances offer hope for the development of preventive HIV vaccine strategies, t he recruitment of volunteers to future clinical trials may well become a stumbling block. This symposium aims to highlight the contribution that social science research has made to this complex process by both addressing the particular nature of HIV infect ion and by placing the topic in a more global context of recruitment to preventive vaccine trials.

Chairs

Guillaume Lachenal , Université Paris – Diderot, France

Jean – Daniel Lelièvre , Vaccine Research Institute, France

15 min – Welcome

François Dabis , Director of the ANRS, France

Yves Lévy, Director of VRI and CEO of Inserm , France

5 min – Recruitment of healthy Volunteers for HIV vaccine Trials: a stumbling Block?

Jean – Daniel Lelièvre , Vaccine Research Institute, France

15 min – Volunteers/Participants Recruitment /Enrolment in Africa

Morenike Folayan , Obafemi Awolowo University, Nigeria

15 min – Exceptional Risk: US Healthy Volunteers’ Perceptions of HIV/AIDS Clinical Trials

Marci Cottingham , University of Amsterdam, The Netherlands

15 min – Participant Recruitment in an Outbreak Context: The Ebola vaccine trials in Sierra Leone

Luisa Enria , University of Bath, UK

45 min – General d iscussion and Round Table : What Kind of Social Science Research to support Clinicians Issues?

Giulio Maria Corbelli, ECAB/EATG , Italy

Frédéric Le Marcis, ENS Lyon, France

Warren Mitchell, AVAC, USA

Caroline Ollivier – Yaniv, Université Paris – Est Créteil, France

10 min – Conclusion

Guillaume Lachenal and Jean – Daniel Lelièvre